Jenburkt Pharmaceuticals Ltd (JENBURPH) Stock Price & News

JENBURPH:NSE

Jenburkt Pharmaceuticals Ltd

₹968.05

+0.13%

(+1.25) 1D

Nov 12, 3:30:00 PM GMT+5:30 · INR

All symbols

	Symbol	Price	Change	% Change

Generating top insights for JENBURPH...

Open

₹969.15

High

₹980.00

Low

₹962.80

Mkt. cap

4.27B

Avg. vol.

1.92K

Volume

806.00

P/E ratio

12.99

52-wk high

₹1,073.90

52-wk low

₹845.00

EPS

₹74.50

No. of employees

801

Open

₹969.15

High

₹980.00

Low

₹962.80

Mkt. cap

4.27B

Avg. vol.

1.92K

Volume

806.00

P/E ratio

12.99

52-wk high

₹1,073.90

52-wk low

₹845.00

EPS

₹74.50

No. of employees

801

Related stocks

Lincoln Pharmaceuticals Ltd

News stories

From web sources and news partners

Benzinga

25 minutes ago

Stock Market Today: Nvidia Rout Sinks Nasdaq, S&P 500 Futures as Board Weighs Jensen Huang’s Future — CRW

FXStreet

2 hours ago

S&P 500: Tech rally offsets post‑CPI selloff – Deutsche Bank

Trefis

3 hours ago

S&P 500 Movers | Winners: SNDK, BE, MU | Losers: ABNB, LULU, MCD

BigGo Finance

7 hours ago

Societe Generale Says S&P 500 Could Hit 8,000 by Year-End, With Three Tailwinds Converging and a Most Bullish Case of 10,000

About Jenburkt Pharmaceuticals Ltd

CEO-

Employees801

Founded1985

Headquarters-

SectorHealth Care

IndustryPharmaceutical industry

Websitejenburkt.com

All values in INR	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	430.24M	446.32M	355.12M	505.71M
Cost of goods sold	87.89M	101.21M	63.22M	99.46M
Cost of revenue	87.89M	101.21M	63.22M	99.46M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	147.14M	95.15M	130.25M	148.74M
Operating expense	276.38M	191.98M	238.04M	261.55M
Total operating expenses	364.27M	293.19M	301.26M	361.02M
Operating income	65.97M	153.13M	53.86M	144.69M
Other non operating income	18.15M	-60.40M	15.13M	-
EBT including unusual items	82.97M	137.08M	67.69M	143.40M
EBT excluding unusual items	82.97M	171.23M	67.69M	143.40M
Income tax expense	23.65M	28.59M	8.84M	41.30M
Effective tax rate	28.51%	20.85%	13.05%	28.80%
Other operating expenses	120.92M	88.74M	101.38M	104.82M
Net income	59.31M	108.49M	58.86M	102.09M
Net profit margin	13.79%	24.31%	16.57%	20.19%
Earnings per share	-	-	-	-
Interest and investment income	-	57.47M	-	-
Interest expense	-1.16M	-392.00K	-1.30M	-1.30M
Net interest expenses	-1.16M	57.07M	-1.30M	-1.30M
Depreciation and amortization charges	8.32M	8.09M	6.41M	7.99M
EBITDA	71.11M	158.72M	59.45M	151.89M
Gain or loss from assets sale	-	-	-	-

Ask anything